Pharmacological activation of Nur77 enhances BMP signalling and inhibits vascular remodelling in pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018
Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension Source: Eur Respir J, 54 (6) 1900378; 10.1183/13993003.00378-2019 Year: 2019
Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1137-1149 Year: 2016
Shroom expression is attenuated in hypoxia-induced pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 147s Year: 2006
TRIM33 prevents pulmonary fibrosis by impairing TGF-ß1 signalling Source: Eur Respir J, 55 (6) 1901346; 10.1183/13993003.01346-2019 Year: 2020
Role of NFATc3 in chronic hypoxia induced pulmonary hypertension in neonatal mice Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010
6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020
Tankyrase(TNKS) inhibiting autophagy promotes the TGF-ß induced EMT process in vitro and Bleomycin(BLM) induced pulmonary fibrosis in rats Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019
17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice. Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018
Heterozygous SOD2 deletion deteriorated chronic intermittent hypoxia-induced lung inflammation and vascular remodeling through mtROS-NLRP3 signaling pathway Source: Virtual Congress 2020 – New insights into sleep apnoea: from diagnosis to treatment Year: 2020
TrkB expression is altered in hypoxia-induced pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 606s Year: 2007
2-Methoxyestrone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008
Loss of Bmp9 does not lead to spontaneous pulmonary hypertension, but attenuates vascular remodeling in experimental models Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020
Genistein rescues pulmonary hypertension and attenuates abnormal vasoconstriction in rats lungs Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012
Dysregulation of TGF-β/BMP signaling in a monocrotaline model of pulmonary hypertension Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006
Effects of BMPR-II signal transduction in the pulmonary vascular remodeling of monocrotaline induced pulmonary hypertension in rats Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008
Lack of RTP801, a suppressor of the mTOR pathway, attenuates cigarette smoke-induced pulmonary injuries in mice Source: Eur Respir J 2007; 30: Suppl. 51, 140s Year: 2007
2-Ethoxyestradiol inhibits vascular and cardiac remodeling and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007
Functional upregulation of PRMT2 in chronic hypoxia-induced pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004